Related Experiment Video
Updated: Aug 14, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Peritumoral Edema and Subcortical Tumor Location in Glioblastoma Outcome Prediction: An Automated Analysis of
Anton Stenwall1, Jesper Nillius1, Joao M Sousa2
1Neurosurgery, Department of Medical Sciences, Uppsala University, 75185 Uppsala, Sweden.
Abstract:
Background: Glioblastoma (GBM) shows marked heterogeneity in overall survival (OS), yet robust radiological prognostic markers remain limited. The prognostic value of peritumoral edema and tumor location remains uncertain. Objective: To evaluate whether peritumoral edema, tumor burden, and spatial tumor distribution predict OS using automated MRI analysis and Brain-Grid-based topographical mapping. Methods: In this retrospective study, preoperative T1-contrast-enhanced and T2-FLAIR MRI sequences from 271 patients with IDH-wildtype GBM were analyzed using automated segmentation (Raidionics). Tumor and edema volumes, edema-to-tumor ratio (ETR), and voxel-wise infiltration patterns were extracted. Location was mapped using the Brain-Grid system. Survival was assessed using Kaplan-Meier and multivariable Cox regression adjusted for age and tumor volume, with correction for multiple testing. Results: In multivariable analysis, only age remained a conventional independent predictor of OS (HR 1.03, p < 0.001). Tumor volume, edema volume, and ETR were not associated with survival. In contrast, Brain-Grid analysis identified two centrally located subcortical voxel regions that remained significantly associated with shorter OS after full adjustment and multiple testing correction. Total number of infiltrated voxels showed no prognostic value. Conclusions: Spatially defined subcortical infiltration patterns, rather than global tumor or edema burden, independently stratify survival in GBM. These findings highlight the prognostic relevance of voxel-level tumor topography and support further validation of Brain-Grid-based imaging biomarkers.